With clinical application and Innovation as the key theme throughout the industry, Imaging in Cancer Drug Development taking place in London, March 2013, focuses on current developments surrounding oncology imaging and overcoming chemical challenges in radiotracer development.

Returning for the 9th consecutive year, Imaging in Cancer Drug Development will reveal latest developments in the industry to optimize your diagnostic processes and maximise your return on investments.

Conference Highlights

• Latest developments in fluorescence and bioluminescence for drug monitoring in xenografts
• Strengths and limitations of whole body optical imaging with X-ray micro CT and multiphoton intravital microscopy
• Overcoming challenges in nuclear tracers for multiscale imaging in oncology
• Current application of PET/SPET modalities and a review of PFS (progression-free survival)
• Practical tools for business expansion in the current economic climate

For more information visit the Conference website Or contact Cem Tuna on 44 0 207 827 6736 or email ctuna@smi-online.co.uk